Manuel Kingsley

Helping CEOs Build Scalable, Exit-Ready Companies

📍 United States🔄 Updated July 2026💼 3 investments📅 5 years investing🗓 Last invested Jul 2024
VC🌍 United States
3
Total investments
1
Early stage
0
Mid stage
1
Late stage
5y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jun 2021
The Investors of Color (IoC) is a national network of diverse accredited investors across the capital stack committed to building wealth for and by underrepresented communities through syndicated investments in early-stage companies.  The IoC is composed of investors representing the entire continuum of capital such as angel investors, venture capital, revenue-based investment firms, family offices, and other capital providers. 
Investor
Jan 2021
Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
Experience · 8 entries
All (8)
Investments (3)
Board (1)
2024
Board Member
Jul 2024
Enduring Hearts funds the most promising research being conducted to increase the longevity of pediatric heart transplants, improve the quality of life for transplant recipients, and ultimately solve the congenital heart defect epidemic, affecting up to 10 out of every 1000 live births, and upwards of 35,000 cases each year. Some of these patients ultimately require a heart transplant as well. As a nonprofit organization, we work with our Scientific Advisory Committee to identify and award operating grants for research projects in organ transplantation and congenital heart disease to members of academic staff at universities, transplant centers and research institutes. We give priority to clinical research projects and new emerging technologies focused on understanding the cause, development and prevention of human transplantation diseases, including organ injury and rejection, viral infection and late graft deterioration. We intend to encourage, not stifle, discovery and innovation by rewarding cutting edge thinking and aggressive studies designed to move the needle rapidly! We hope to see a day when a child born with congenital or acquired end-stage heart failure can avoid a heart transplant in order to survive - or if one is required, the ability to live with the same donated organ for a lifetime.
2022
Managing Partner
Jan 2022
We help business owners and corporate leaders turn your Team into a growth engine—without more hustle, more meetings, or more headaches. Clarity. Alignment. Execution
2021
Angel Investor
Jun 2021
The Investors of Color (IoC) is a national network of diverse accredited investors across the capital stack committed to building wealth for and by underrepresented communities through syndicated investments in early-stage companies.  The IoC is composed of investors representing the entire continuum of capital such as angel investors, venture capital, revenue-based investment firms, family offices, and other capital providers. 
Investor
Jan 2021
Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
2020
RADx Initiative External Commercial Partnerships - Team Lead (Contract)
Apr 2020
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelors degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement
Show all 8 entries ↓
Investment activity
2021–2024 · 3 investments
2021220241
Recent (last 2 years)Earlier